Novonix (NVNXF) Invested Capital (2020 - 2025)

Novonix has reported Invested Capital for 6 years, with the latest figure at $141.2 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital rose 29.91% year-over-year to $141.2 million; the trailing twelve-month figure through Dec 2025 stood at $141.2 million (up 29.91% YoY), and the FY2023 full-year result was $193.3 million, down 31.89% from the prior year.
• Invested Capital for Q4 2025 stood at $141.2 million, down from $258.2 million in the prior quarter.
• The five-year high for Invested Capital was $365.3 million in Q2 2022, with the low at $30.9 million in Q2 2024.
• Historically, Invested Capital has averaged $185.2 million across 5 years, with a median of $196.3 million in 2023.
• Annual changes were most pronounced in 2024 — Invested Capital plunged 84.52% — and 2025, when it surged 736.76%.
• Novonix's Invested Capital stood at $35.2 million in 2021, then surged by 706.76% to $283.8 million in 2022, then sank by 31.89% to $193.3 million in 2023, then sank by 43.76% to $108.7 million in 2024, then gained by 29.91% to $141.2 million in 2025.
• The last three Invested Capital figures came in at $141.2 million (Q4 2025), $258.2 million (Q2 2025), and $108.7 million (Q4 2024), per Business Quant data.